Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

Memantine as an add-on therapy to clozapine may improve schizophrenia negative symptoms and cognitive functioning.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital de Clinicas de Porto Alegre
• Treatments: Clozapine; Memantine

Criteria

Inclusion Criteria:

• Under clozapine with negative symptoms

Exclusion Criteria:

• Pregnancy

• Lactation